Cyclosporine-induced syngeneic graft-vs-host disease: Prevention of autoaggression by treatment with monoclonal antibodies to t lymphocyte cell surface determinants and to mhc class ii antigens
Allan D. Hess, Louis R. Hoewitz, Mary K. Laulis, Ephraim Fuchs
Dive into the research topics of 'Cyclosporine-induced syngeneic graft-vs-host disease: Prevention of autoaggression by treatment with monoclonal antibodies to t lymphocyte cell surface determinants and to mhc class ii antigens'. Together they form a unique fingerprint.